Goodwin was named the most active law firm globally and in the US for representing companies in M&A transactions, according to PitchBook’s Q2 2024 Global League Tables. Mergermarket M&A Deal Drivers (Americas and EMEA) League Tables recognized Goodwin as a leading firm in categories including Pharma, Medical & Biotech M&A and Technology, Media & Telecom M&A. Goodwin earned the number one firm advisor ranking for All Private Equity Stages and Venture Capital Rounds by deal count in the LSEG H1 2024 Global Venture Capital and Private Equity Legal Advisory League Tables.
The rankings reflect Goodwin’s robust industry-specific focus and client-centric approach. The firm serves as trusted advisors to capital markets, M&A, private equity, technology, healthcare, venture capital, life sciences, real estate, financial services, and other clients across select industry verticals and geographies.
Goodwin’s H1/Q2 2024 league table results include:
Mergermarket M&A Deal Drivers (Americas)
- #1 All Sectors: Mid-Market ($5m - $250m) M&A (by deal count and by deal value)
- #1 Pharma, Medical & Biotech M&A (by deal count)
- #1 Technology, Media & Telecom M&A (by deal count)
- #2 All Sectors M&A (by deal count)
- #2 Industrials & Chemicals M&A (by deal count)
Mergermarket M&A Deal Drivers (EMEA) (by deal count)
- #1 All Sectors: Mid-Market (€5m-€250m) M&A
- #2 Pharma, Medical & Biotech M&A
- #4 Technology, Media & Telecom M&A
PitchBook Global League Tables (by deal count)
- #1 M&A - Most active globally: companies
- #1 M&A - Most active in US: companies
- #1 Venture Capital - Exits
- #1 Venture Capital - Transportation
- #2 All Deals Combined - Global
- #2 Venture Capital - Pharma & BioTech
- #2 Private Equity - IT
- #3 M&A - US
- #3 All Deals Combined - US
- #3 Venture Capital - Europe
- #3 Venture Capital - IT hardware
- #3 Venture Capital - Media
- #3 Private Equity - Buyouts
- #3 Private Equity - Other PE Deals
- #3 Private Equity - Global
- #4 Venture Capital - Late stage
- #4 Venture Capital - US
- #4 Venture Capital - Energy
- #4 Venture Capital - HC devices & supplies
- #4 Venture Capital - HC services & systems
- #4 Venture Capital - Software
- #4 Private Equity - B2C
- #4 Private Equity - Healthcare
LSEG Global PE/VC (by deal count)
- #1 Advisor to Firm - All Private Equity Stages
- #1 Advisor to Firm - VC Rounds
- #2 Advisor to Company - All Private Equity Stages
- #2 Advisor to Company - VC Rounds
- #4 Advisor to Company - LBO & Related Rounds
- #4 Advisor to Firm - LBO & Related Rounds
LSEG Global Mid-Market M&A (by deal count)
- #1 Global Mid-Market
- #1 US Target Mid-Market
- #2 French Involvement Mid-Market
- #3 UK Involvement Mid-Market
- #3 European Involvement Mid-Market
- #4 Hong Kong Involvement Mid-Market
LSEG Global Small-Cap M&A (by deal count)
- #1 Global Small-Cap
- #2 US Target Small-Cap
- #2 French Involvement Small-Cap
- #3 Hong Kong Involvement Small-Cap
- #3 European Involvement Small-Cap
- #4 UK Involvement Small-Cap
LSEG Global Capital Markets (by deal count)
- #3 US Equity & Equity-related (Issuer)
- #4 US Equity & Equity-related (UW)
- #5 Global Equity & Equity-related (Issuer)
The Deal (by deal count)
- #3 PIPES (Issuer Counsel)
- #5 Global PE